Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography
about
Pharmacological cardioversion for atrial fibrillation and flutterManaging Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial FibrillationFlecainide: Current status and perspectives in arrhythmia managementPreventable stroke and stroke preventionDrug therapy for atrial fibrillation2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.Vernakalant is superior to ibutilide for achieving sinus rhythm in patients with recent-onset atrial fibrillation: a randomized controlled trial at the emergency department.Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillationBleeding Risk Index in an anticoagulation clinic. Assessment by indication and implications for careNarrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.Antithrombotic Regimens for Patients Taking Oral Anticoagulation After Coronary Intervention: A Meta-analysis of 16 Clinical Trials and 9,185 Patients.Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.Rhythm control and cardioversionRhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat.Rate control vs. rhythm control in the management of atrial fibrillation in elderly persons.Calcium channel blocker class heterogeneity: select aspects of pharmacokinetics and pharmacodynamics.Treating atrial fibrillation. What is the consensus now?The safety of digoxin as a pharmacological treatment of atrial fibrillation.Electrical cardioversion for AF-the state of the art.Antithrombotic therapy in atrial fibrillation: aspirin is rarely the right choice.Ibutilide for treatment of atrial fibrillation in the emergency departmentAtrial fibrillation: insights from clinical trials and novel treatment options.Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical frameworkAtrial fibrillation in heart failure: The sword of Damocles revisited.Efficacy And Safety of Dabigatran Etexilate Utilization With Concomitant Dual Antiplatelet Therapy In Atrial FibrillationThe Role of Echocardiography as a Predictor of the Incidence and Progression of Atrial Fibrillation.Cardioversion for atrial fibrillation: treatment options and advances.Recent advances in oral anticoagulation for atrial fibrillation.Stroke prevention treatment of patients with atrial fibrillation: old and new.Atrial fibrillation: an epidemic in the elderly.Safety of flecainide.Flecainide acetate for the treatment of atrial and ventricular arrhythmias.Predictors of long-term maintenance of normal sinus rhythm after successful electrical cardioversion.Management of oral anticoagulation in the surgical patient.Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial FibrillationBleeding complication of triple therapy of rivaroxaban, prasugrel, and aspirin: a case report and general discussion.Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects.A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.Programmed inappropriate ICD ventricular defibrillation for cardioversion of persistent atrial fibrillation.Identification of metabolic pathways and enzyme systems involved in the in vitro human hepatic metabolism of dronedarone, a potent new oral antiarrhythmic drug.
P2860
Q24246997-2FFB9A41-5633-4226-994E-80B343F502EDQ28080247-C6DFE27C-850B-439F-9DB3-AD5725C11D68Q28081935-4FC73668-1493-48AC-9329-C46F68CD317FQ28187602-3FB84208-110A-4617-B781-D19E9A43F6B3Q28218580-CC7EE7EB-0F14-4406-9327-5C3662610E39Q30653045-761EDF70-9D56-407F-9228-33C6C3D013D4Q33589789-0A45075A-DB37-4E25-9A1A-27196186A8D8Q34505579-DD6C3A04-5961-4DA6-A522-6CD73415B2E9Q34724446-8B502382-B8A5-4384-83B3-27E75FC1E0DAQ35547234-809549AD-0D49-438B-856C-2CFE6BEDB3A8Q35627390-0E39872D-8629-411F-9544-2B1088A103B9Q35771784-1AE800D8-8F88-4D69-AAA9-45096B51190EQ35772996-26A09529-3BB4-4590-96C8-E85356EFD73BQ35826963-633404C4-C4C5-4F49-97A2-E4D6D540F9F9Q36077780-83D3D9C1-2C99-43F7-8078-95E579125FF8Q36109576-85724F46-8CB9-47B7-B66F-0C34C8D6100CQ36316479-485BB63F-0392-4240-935B-61C43E9B284EQ36446911-3E4957D7-2A67-484F-8726-EAE1298D85E8Q36793204-C768BEE0-9AC2-4CBE-944A-E0F852EEAB86Q36876659-2D94295D-865E-4347-8906-B47EB78EA813Q36929148-E34FDA18-F46B-45DB-919B-A0D7B3744CD6Q37008941-D506CBBB-0909-4A8E-9171-388AEDDD688DQ37013160-FC214F38-547B-4D0E-91A1-B2AC9F35FD02Q37043226-23E7699F-A7DF-4D78-98BC-F5CD52EFB9BCQ37115151-8D4EE9D4-162B-427F-92DD-DAD5BE2CB96CQ37496284-3E6E3CF0-B95E-43A5-8D56-A1C8E46A2EC1Q37573899-7B8BF21C-775F-4AB2-A484-43092B643DC4Q37802084-FA5026F9-7920-4521-B917-308A957D7D58Q37810505-31C2D6FE-85C0-4B91-ACC2-0B290B99C7EFQ37923979-BBB8536B-1C46-4FA8-88AF-8517C2A92AD2Q37995638-C4367649-C500-42D3-906B-772763914D3DQ38072091-788F65CD-103E-4972-8E5C-749864FAD685Q38202066-97A90320-A00D-4C7A-82A8-7498AC8DE26BQ38429313-667E0C1C-A604-4741-A363-AC7FDBC40E63Q38790430-05D1FDC9-3747-46D8-AA93-A82AE6D1614CQ39121292-1B62417D-B4ED-4B86-A06F-254C852B2011Q39816038-2D689B14-CE11-4863-9C75-F99E064BD93DQ40771901-05FBACDB-462B-4167-99D7-6AD6FDEB7827Q41947052-D2420110-1027-45FE-966D-FFD85CF64AB7Q42930821-682C25D2-6B92-4D66-84AC-E92F2C94B1AF
P2860
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography
description
2003 nî lūn-bûn
@nan
2003 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Management of atrial fibrillat ...... oversion, and echocardiography
@ast
Management of atrial fibrillat ...... oversion, and echocardiography
@en
Management of atrial fibrillat ...... oversion, and echocardiography
@nl
type
label
Management of atrial fibrillat ...... oversion, and echocardiography
@ast
Management of atrial fibrillat ...... oversion, and echocardiography
@en
Management of atrial fibrillat ...... oversion, and echocardiography
@nl
prefLabel
Management of atrial fibrillat ...... oversion, and echocardiography
@ast
Management of atrial fibrillat ...... oversion, and echocardiography
@en
Management of atrial fibrillat ...... oversion, and echocardiography
@nl
P2093
P921
P1476
Management of atrial fibrillat ...... oversion, and echocardiography
@en
P2093
Eric B Bass
Jodi B Segal
Leonardo J Tamariz
Robert L McNamara
P304
P356
10.7326/0003-4819-139-12-200312160-00012
P407
P577
2003-12-16T00:00:00Z